UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] RSS 2.0 [feed] RSS 1.0 [feed] Atom
Group by: Author | Type
Jump to: C | J | L | N | T | V | W
Number of items: 11.

C

Cano, SJ and Zajicek, JP and Thompson, AJ and Hobart, JC (2007) Beware all neurologists: The FDA's tough new requirements for rating scale performance are coming to a study near you soon. In: JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. (pp. 1031 - 1031). B M J PUBLISHING GROUP

J

Jenkins, TM and Thompson, AJ (2007) GPs have pivotal role in managing MS. Practitioner , 251 (1694) 37 - passim.

L

Leary, SM and Thompson, AJ (2007) Treatment for patients with primary progressive multiple sclerosis. In: Cohen, JA and Rudick, RA, (eds.) Multiple sclerosis therapeutics. (751 - 760). informa healthcare: London.

N

Nicholas, R and Chataway, J (2007) Multiple sclerosis. In: UNSPECIFIED

T

Taylor, TL and Hawton, K and Fortune, S and Kapur, N (2007) Attitudes towards and satisfaction with services among deliberate self-harm patients: A systematic review of the literature. National Co-ordinating Centre for NHS Service Delivery and Organisation R&D: London.

Taylor, TL and Montgomery, P (2007) Can cognitive-behavioral therapy increase self-esteem among depressed adolescents? Children and Youth Services Review , 29 (7) 823 - 839. 10.1016/j.childyouth.2007.01.010.

Thompson, AJ (2007) Measuring the outcomes in neurorehabilitation. In: MULTIPLE SCLEROSIS. (pp. S14 - S15). SAGE PUBLICATIONS LTD

Thompson, AJ (2007) Principles of neurorehabilitation and its application to chronic neurological disorders. NEUROLOGIA 1 - 8.

Thompson, AJ (2007) Promises, promises... ANN NEUROL , 61 (1) 1 - 2. 10.1002/ana.21083.

V

van Ter Linden, FAH and Kragt, JJ and Hobart, JH and Klein, M and Thompson, AJ and van der Ploeg, HM and Polman, CH and Uitdehaag, BMJ (2007) Proxy measurements in MS: does patient's cognitive impairment influence patient-proxy agreement on disease impact? In: MULTIPLE SCLEROSIS. (pp. S213 - S213). SAGE PUBLICATIONS LTD

W

Wolinsky, J and Narayana, PA and O'Connor, P and Coyle, PK and Ford, C and Johnson, K and et al, (2007) Glatiramer acetate in primary progressive multiple sclerosis: results of a multinational, multicenter, double-blind, placebo-controlled trial. Annals of Neurology , 61 (1) 14 - 24.

This list was generated on Tue May 21 15:24:12 2013 BST.